0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical)

Buy Now

Combating Fungal Infections - Problems and Remedy (Paperback, 2010 ed.) Loot Price: R5,841
Discovery Miles 58 410
Combating Fungal Infections - Problems and Remedy (Paperback, 2010 ed.): Iqbal Ahmad, Mohammad Owais, Mohammed Shahid, Farrukh...

Combating Fungal Infections - Problems and Remedy (Paperback, 2010 ed.)

Iqbal Ahmad, Mohammad Owais, Mohammed Shahid, Farrukh Aqil

 (sign in to rate)
Loot Price R5,841 Discovery Miles 58 410 | Repayment Terms: R547 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated.

General

Imprint: Springer-Verlag
Country of origin: Germany
Release date: December 2014
First published: 2010
Editors: Iqbal Ahmad • Mohammad Owais • Mohammed Shahid • Farrukh Aqil
Dimensions: 235 x 155 x 29mm (L x W x T)
Format: Paperback
Pages: 539
Edition: 2010 ed.
ISBN-13: 978-3-642-44672-6
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 3-642-44672-8
Barcode: 9783642446726

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners